Here, we recategorized participants of each dataset into four subgroups (Q1, Q2, Q3, and Q4) according to the expression levels of KIF11. In Figure 3A, the mRNA levels of KIF11 significantly impacted poor OS (left) of breast cancer in none‐TCGA datasets. This evidence concerns the gene KIF11 and breast cancer.